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Monday, March 7, 2011 295amitochondria CRC (287517 vs. 180512 nM/mg mitochondrial protein,
p<0.05), but it had no effect on CRC from mitochondria of GPER-/- hearts
(170533 vs. 16757 nM/mg mitochondrial protein). These results conclu-
sively demonstrate that GPER plays an important role in mediating rapid
E2-induced cardioprotection after ischemia/reperfusion. Supported by NIH.
1598-Pos Board B508
Validation of Reperfusion Duration for Myocardial Infarction Assessment
in the Langendorff Ischemia Model of Isolated Mouse Heart
Jean Chrisostome Bopassa, Ligia Toro, Enrico Stefani.
Introduction: Perfused isolated heart is a widely used ex-vivo organ model as it
allows rigorous control of parameters what is not readily achievable by an in
vivo model. However, there is disagreement on the reperfusion duration to as-
sess the myocardial infarction by TTC staining. Many authors have used long
reperfusion times (~120 min) in conditions where the hearts during ischemia
were suspended in air water-jacketed chamber maintained at37C. Others
have determined myocardial infarction with short reperfusion durations
(30-40min) where the hearts were submerged in a normothermic physiological
solution. In this work where hearts were immersed in Krebs Henseleit (KH) so-
lution during ischemia we demonstrated that a reperfusion duration of 40 min is
adequate to determine infarct size after ischemia as longer reperfusion times of
60 and 90 min showed the same maximal infarct size.
Methods and Result:We compared different reperfusion durations (40, 60 and
90 min) of isolated mice hearts immersed in KH buffer after 18 min of normo-
thermic ischemia. Hearts were perfused using Langendorff apparatus with KH
buffer oxygenated with 95% O2 þ 5% CO2 at37C. The heart function was
recorded and myocardial infarction assessed by TTC staining at the end of
reperfusion. Our data show no significant difference between the groups reper-
fused for 40, 60 or 90 min in infarct size and heart function recovery.
Conclusion: These results indicate that when the isolated mice hearts are im-
mersed in a normothermic physiological solution during ischemia, reperfusion
for 40 min is sufficient to reach the maximum infarction.
1599-Pos Board B509
Ivabradine and Mechanical Unloading Increase Sarcoplasmic Reticulum
Calcium Content in a Rodent Model of Heart Failure
Manoraj Navaratnarajah, Carin van Doorn, Urszula Siedlecka,
Michael Ibrahim, Ajay Gandhi, Adarsh Shah, Magdi H. Yacoub,
Cesare M. Terracciano.
Improvements in Ca2þ handling, and sarcoplasmic reticulum (SR) Ca2þ
regulation in particular, are associated with myocardial recovery in patients
with end stage heart failure (HF) treated with left ventricular assist devices
(LVAD). Ivabradine (IV), a novel heart rate reducing agent has been shown to
have positive Ca2þ regulatory effects in rodent HF, and is used in human HF ther-
apy; however, the effects of IV during LVAD treatment have not been studied.
We studied the chronic effects of IV on cellular Ca2þ handling during mechan-
ical unloading (MU) of HF hearts. HF was induced by left coronary artery
ligation and was characterized by reduced ejection fraction (EF), smaller
Ca2þ transient amplitude (CaT) and reduced SR Ca2þ content compared to
age matched sham operated animals (SH). MU (4 weeks) was achieved by
heterotopic abdominal heart transplantation and IV (10mg/kg/day) was admin-
istered for 4 weeks. Isolated ventricular myocytes were loaded with Indo-1 AM
and field stimulated at 1 Hz.
CaT was significantly elevated in the MUþIV group (indo-1 ratio units):
MUþIV: 0.25 5 0.06 (n=45) p< 0.001 vs MU: 0.18 5 0.05 (n=40), and
p<0.001 vs SH: 0.175 0.05 (n=45)). IV augmented SR Ca2þ content in com-
bination with MU compared with MU alone and to a level even greater than
SH: SR Ca2þ content (indo-1 ratio units): MUþIV: 0.27 5 0.07 (n=45) p<
0.05 vs MU: 0.245 0.05 (n=40), and p<0.001 vs SH: 0.225 0.07 (n=45))
Our results show that IV treatment combined with mechanical unloading
induces a larger increase of Ca2þ transient amplitude and SR Ca2þ content
compared with mechanical unloading alone. These effects may be exploited
to enhance myocardial recovery in patients receiving LVAD therapy for HF.
1600-Pos Board B510
Bioenergetic Supply and Demand in the Cardiomyocyte
Edmund J. Crampin.
The mechanisms that regulate the control of energy demand and supply in the
myocardium are crucial for maintaining normal cardiac function. Although
a number of mechanisms have been proffered by which mitochondrial supply
of ATP can change to match varying workload in the myocardium, identifying
the underlying regulatory pathways remains controversial.
We describe an approach to studying this problem in which thermodynamically
consistent mathematical models of the key energy-consuming processes in the
cardiomyocyte (sarcoplasmic endoplasmic reticulum calcium ATPase
(SERCA)[1], sodium pump[2] and the acto-myosin cross-bridge cycle[3]) arecoupled to a model of mitochondrial ATP production within a whole-cell mod-
elling framework for cardiac excitation-contraction coupling[4].
We use the model to investigate the metabolic stability hypothesis, wherein en-
ergy demand-supply homeostasis is maintained despite negligible variation in
metabolite concentrations at varying cardiac workloads. We find that under
physiological workloads cellular metabolite concentrations do not change
significantly with increasing workload if a proposed feedback of inorganic
phosphate onto mitochondrial oxidative phosphorylation is present, consistent
with the proposition that Pi-regulation alone is sufficient to maintain metabolic
homeostasis in the absence of other regulatory mechanisms.
Finally, we use our model to address the empirically observed linearity of the
cardiac ATP vs. Force-Length-Area curve (the cellular equivalent of the VO2
vs. Pressure-Volume-Area relationship). We show that the apparent linearity
arises from the near irreversibility of the cross-bridge cycle, but that the linear
relationship may disappear at cardiac workloads high enough that cellular
metabolite concentrations start to vary.
[1] Biophysical Journal 96, 2029-2042, 2009
[2] American Journal of Physiology, Heart and Circulatory Physiology 293,
H3036-H3045, 2007
[3] Biophysical Journal 98, 267-276, 2010
[4] Biophysical Journal 90, 3074-3090, 2006
1601-Pos Board B511
Stimulation of Cardiac Neoangiogenesis by Estrogen Therapy is One of the
Key Mechanisms in Reversing Advanced Heart Failure
Andrea Iorga, Rod Partow-Navid, Humann Matori, Rangarajan Nadadur,
Jingyuan Li, Soban Umar, Mansoureh Eghbali.
Estrogen(E2) has been shown to regulate angiogenesis in different tissues, but it
is still not known if E2 could stimulate angiogenesis in the heart. Recently, we
showed that E2 rescues advanced heart failure by reversing the myocardial
contractile deficiency and restoring ejection fraction from ~30% to ~55%.
Here we examined whether stimulation of angiogenesis in the heart is a mech-
anism involved in the E2-induced rescue of HF. Trans-aortic constriction(TAC)
procedure was used to induce HF. Once the ejection fraction(EF) reached
~30%, one group of mice was sacrificed and the other two groups were treated
with E2(30 mg/kg/day, n=16), or E2 plus the angiogenesis inhibitor TNP-470
(TNP, 30 mg/kg, n=4) for 10 days. Serial echocardiography, real-time PCR
and immunocytochemistry were performed. RT-PCR showed that the transcript
levels of two markers of angiogenesis, vascular endothelial growth factor
(VEGF) and hypoxia-inducible factor-1a(HIF1a), were ~10 fold downregulated
in HF(0.1750.06 for VEGF and 0.2650.01 for HiF1a; normalized to CTRL).
E2 treatment was not only able to reverse VEGF and HIF1a transcript level
downregulation observed in HF, but to even upregulate both transcripts 3
fold higher than in healthy controls(3.2450.1 for VEGF and 3.1650.09 for
HIF1a). Quantification of capillary density also revealed that E2 therapy not
only completely reversed the loss of capillaries in HF, but significantly en-
hanced capillary density by ~ 4 fold compared to HF(2.8350.14 in E2 vs.
0.6650.07 in HF, normalized to CTRL). Interestingly, E2 failed to rescue
HF in the presence of TNP-470 (E2þTNP group) as EF (29.352.1%) was
not significantly improved after 10 days of therapy. The capillary density of
HF mice also did not improve in E2þTNP group(0.5350.07). These data
strongly support the vital role of angiogenesis in the rescue action of E2.
1602-Pos Board B512
Estrogen Receptor Beta, but Not Alpha, is the Key Player in Restoration
of Heart Function of Heart Failure Mice by Estrogen Therapy
Andrea Iorga, Rod Partow-Navid, Rangarajan Nadadur, Humann Matori,
Jingyuan Li, Soban Umar, Mansoureh Eghbali.
Recently we discovered that estrogen(E2) therapy can rescue advanced heart
failure(HF) induced by pressure overload in mice. Most of the biological
actions of estrogen are mediated thorough estrogen receptors alpha(ERa) and
beta(ERb), and both of these receptors are present in the heart. Here we inves-
tigated which estrogen receptor(s) are involved in the rescue by estrogen. We
used the transaortic constriction(TAC) procedure to induce HF. Once the ejec-
tion fraction(EF) reached ~30%, one group of animals was sacrificed(HF
group), and the other three groups received either 17b-estradiol (30 ug/kg/
day), selective ERa agonist (PPT, 0.625mg/kg/day), or selective ERb agonist
(DPN, 0.625mg/kg/day) for 10 days. Serial echocardiography was performed
and LV pressure was measured by direct catheterization before sacrifice. As ex-
pected, E2 rescued HF by restoring EF from 33.1751.12% to 53.0551.29%.
Interestingly, mice treated with ERb agonist had a significant improvement in
their EF from 33.1751.12% to 45.2552.1%(n=7), whereas the EF of mice
treated with ERa agonist did not improve at all(31.0952.3%, n=6). Similar
to EF, only fractional shortening of DPN-treated mice improved from
15.750.58% in HF to 21.9551.65% in DPN vs. 14.7251.24% in PPT).
Next, we examined the mechanical performance of the LV in mice treated
296a Monday, March 7, 2011with DPN and PPT. DPN treatment improved LVDP from 94.6855.14 in HF
to 119.355.5 and RPP from 39749.954527.03 in HF to 62794.0455534.62.
PPT treatment had no effect on LV mechanical performance as both LVDP and
RPP were not significantly different from their corresponding values in HF.
The relaxation and contraction defects of HF mice (dP/dtmax and dP/dtmin)
were also partially restored by DPN but not by PPT. Our data strongly support
the view that ERb is the main player in rescuing advanced HF by E2.
1603-Pos Board B513
Phosphorylation of GSK-3b is Required for Intralipid to Protect the Heart
Against Ischemia/Reperfusion Injury
Siamak Rahman, Jingyuan Li, Jean C. Bopassa, Andrea Iorga,
Parisa Partownavid, Mansoureh Eghbali.
Recently we found that administration of Intralipid (ILP) during reperfusion
significantly improves post-ischemic cardiac function and reduces the myocar-
dial infarct size by ~70% , both in the isolated mouse heart and in-vivo rat heart.
Here we investigated whether ILP-induced cardioprotection is mediated
through the inhibition of GSK-3b. Wild type (WT) C57BL/6 male mice and
GSK-3b Knockin (KI) were used. The isolated hearts were subjected to 20
min of global normothermic ischemia followed by reperfusion with 1% ILP
(40 min for heart function and infarct size and 10 min for calcium retention
capacity (CRC) experiments). The left ventricular (LV) systolic pressure, LV
end-diastolic pressure (LVDP), heart rate, maximum velocity of contraction
(dP/dt max) and maximum velocity of relaxation (dP/dt min) were recorded.
Myocardial necrosis was assessed using TTC staining. Mitochondria were iso-
lated to measure CRC by calculating the number of pulses required to trigger
the opening of the mitochondrial transition permeability pore as a result of cal-
cium overload. Before ischemia, the baseline RPP, LVDP, dP/dtmax and dP/
dtmin in GSK-3b KI mice were similar to WT. However, the functional recov-
ery during reperfusion was very poor in GSK-3b KI mice. At the end of 40 min
of reperfusion, the RPP was 19905499 in GSK-3b KI mice vs.
1540551011mmHg*beats/min in WT, the LV dP/dtmax was 239.7517.8 in
GSK-3b KI vs. 27035145 mmHg/s in WT and the LV dP/dtmin was
219514 in GSK-3b KI vs. 1683566 mmHg/s in WT. The infarct size was sig-
nificantly larger compared to WT (45.3510.3 vs. 16.752.33% in WT,
P<0.001). Postischemic administration of ILP in GSK-3b KI mice demon-
strated lower CRC than WT (1.350.1 vs. 2.750.06 mM/mg-mitochondrial
protein in WT). In conclusions, these data demonstrate that phosphoryltaion
of GSK-3b is required for the cardioprotective action of ILP.
1604-Pos Board B514
CVT Inhibits the Intralipid Rescue of Bupivacaine-Induced Cardiotoxicity
in a Dose-Dependant Manner
Parisa Partownavid, Soban Umar, Siamak Rahman, Mansoureh Eghbali.
Intralipid (ILP) is effective in resuscitating Bupivacaine-induced cardiac arrest,
but it’s mechanism of action is not clear. Here we investigated whether protec-
tive action of ILP is mediated through fatty acid oxidation pathway using
CVT-4325, a fatty acid oxidation inhibitor. Male Sprague-Dawley rats (300-
350 g) were anesthetized (ketamine (80mg/kg) and xylazine (8mg/kg, i.p.))
and then ventilated. In control (CTRL, n=8), asystole was achieved with a single
dose of Bupivacaine (10mg/kg over 20 seconds, i.v.) and then resuscitation was
started immediately using ILP (5ml/kg bolus, and 0.5ml/kg/min maintenance)
together with cardiac massage. In CVT group (n=12), the protocol was identical
to CTRL, except that rats were pre-treated with different doses of CVT (0.5,
0.25, 0.125 and 0.0625mg/kg bolus i.v.) for 5 min. The heart rate (HR), ejection
fraction (EF) and fractional shortening (FS) were measured by echocardiogra-
phy. As expected, in CTRL group, administration of Bupivacaine resulted
in asystole and ILP improved HR and cardiac function gradually within
10 min; HR increased from 7353beats/min at 1 min to 180523beats/min
at 5min, and further to 243520beats/min at 10min. The left ventricular systolic
function fully recovered in all rats within 5min of ILP treatment (EF=7053%,
FS=4053%). In CVT pretreated group, however, there was no recovery of car-
diac function with ILP at CVT doses of 0.5, 0.25 and 0.125mg/kg within 10min
of ILP therapy. ILP was only able to rescue Bupivacaine-induced cardiotoxicity
at lowest dose of 0.0625 mg/kg CVT as cardiac function improved gradually
within 10min (HR from 65 at 1min to ~170min at 10 min; EF=~55%,
FS=~29% at 10min and QRS from 33 ms at 1 min to 27 ms at 10 min). In
conclusion CVT-4325 prevents intralipid rescue of Bupivacaine-induced cardi-
otoxicity in a dose dependant manner.
1605-Pos Board B515
Elasticity of Developing Cardiac Tissue and Influence on Early Cardio-
myocyte Beating
Stephanie F. Majkut, Dennis E. Discher.
Recent studies have demonstrated the effects of cardiomyocyte mechano-
sensitivity to ECM elasticity on beating physiology of 10 day chick embryocardiomyocytes[1] and also of neonatal rat cardiomyocytes[2], developmen-
tal stages for which the heart mechanics are established and the Young’s
modulus is E~10-20 kPa. Here we study the evolution of embryonic cardiac
tissue mechanics in parallel with the effects of microenvironment mechanics
on individual cardiomyocyte function throughout early development. To
measure the changing mechanical properties of cardiac tissue, we used mi-
cropipette aspiration to measure local and average bulk elastic moduli of
embryonic avian heart tissue. We observe stiffening of the looping heart
tube (days 2-4) from 1 kPa average elasticity to 2 kPa. We measure a greater
local elastic modulus in the inner curvature of the looping heart tube than
the outer curvature. Treating heart tubes with blebbistatin led to a uniform
30% decrease in elasticity, indicating that the local elasticity is not solely
due to actomyosin contractility. We performed a proteomic analysis of var-
ious anatomical positions along the 2-4 day heart tubes by mass spectrom-
etry, to measure the relative spaciotemporal changes in protein expression.
To explore the effects of the immediate microenvironment mechanics on
early cardiomyocyte function, heart cells were isolated from 2-4 day
chicken embryos, cultured on collagen-coated polyacrylamide gels of vary-
ing stiffness, and observed for effects of substrate elasticity on spontaneous
beating and morphology. After 24 hours in culture, cardiomyocyte beating
magnitude was larger on softer 1 kPa gels than on stiffer 5-34 kPa gels,
with no measurable difference in behavior with developmental stage.
[1] A. Engler et al. Journal of Cell Science 121: 3794-3802 (2008).
[2] J. Jacot, et al. Biophysical Journal 95(7): 3479-3487 (2008).
1606-Pos Board B516
Mechanisms of Prevention of Pulmonary Hypertension-Induced Right-
Ventricular Failure by Intralipid
Soban Umar, Rod Partow-Navid, Federica Maltese, Humann Matori,
Andrea Iorga, Parisa Partownavid, Mansoureh Eghbali.
Intralipid (ILP) has been used for treatment of local anesthetic-induced cardiac-
arrest and as source of parenteral nutrition. Some of its constituents are precur-
sors of pulmonary vasodilator prostaglandins. Pulmonary hypertension (PH) is
associated with pulmonary vascular remodeling leading to right-ventricular
(RV) hypertrophy and failure. Recently we found that ILP prevents PH in
rats. Here we investigated the mechanisms involved in this prevention. Rats
were treated with monocrotaline(60 mg/kg) to induce PH, and then either re-
ceived daily ILP (1 mL of 20% ILP/day) for 30days or left untreated to develop
RV failure (RVF). Saline treated rats served as control. Serial echocardiogra-
phy was performed to monitor cardiopulmonary hemodynamics., RV pressure
(RVP) was recorded by direct cardiac catheterization right before sacrifice.
Immunohistochemistry, confocal-microscopy, Western Blot analysis and RT-
PCR were performed. RVF group developed PH that led to RVF later with
significantly increased RVP (7055mmHg,n=10) and depressed RV ejection
fraction (RVEF=3452%). Severe structural changes in RV and lung were
observed in RVF group including RV-hypertrophy, increased lung weight, pul-
monary medial hypertrophy, fibrosis, apoptosis (upregulation of Caspase-3
(~10fold)), inflammation (increased expression of IL-6) and suppression of
angiogenesis (decreased VEGF and capillary-density). Furthermore, RVF
was associated with downregulation of phospho-eNOS(~4fold), Caveolin-1
(~6fold) adenosine-A2B receptor and estrogen receptor-b in lungs. In the
RV, adenosine-A2A receptor and estrogen receptor-b were downregulated in
RVF. ILP therapy prevented PH-induced RVF by restoring RVP
(3052mmHg,n=8) and RVEF(6351.5%) and attenuating RV hypertrophy
and lung remodeling. ILP suppressed inflammation and fibrosis along-with
improving angiogenesis and restoring phospho-eNOS, Caveolin-1 in lungs
and Caspase-3, adenosine-A2 and estrogen receptor-b expression in lungs
and RV. In conclusion ILP prevented PH and RV-failure by preserving cardio-
pulmonary structure and function and enhancing perfusion via adenosine
receptor, estrogen receptor-b and eNOS-mediated mechanisms.
1607-Pos Board B517
Sex Differences in the Mechanical Properties of Rat Myocardium After
Exposure to Simulated Microgravity
Mihail I. Mitov, Adam Tilley, Adhijit Patwardhan,
Esther E. Dupont-Versteegden, Kenneth S. Campbell.
Female astronauts are more likely than male astronauts to develop presyncope
and orthostatic intolerance when they return to normal gravity after space-
flights. The underlying mechanisms for this are unclear but could include
myocardial adaptations to micro-gravity conditions. This study was designed
to test whether there are sex-specific changes in the mechanical properties of
myocardial tissue in rats subjected to a period of simulated microgravity. Mul-
ticellular myocardial preparations were isolated from control male and female
Sprague-Dawley rats and corresponding experimental animals that were hind-
limb unloaded (HLU) for 14 days. Preparations were subjected to standard
mechanical tests imposed under muscle length control in solutions with pCa
